Lycia Therapeutics announces the closing of an enlarged initial public offering and full exercise of the underwriters' option to purchase additional shares.
Lycia Therapeutics announces the closing of an enlarged initial public offering and full exercise of the underwriters' option to purchase additional shares.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in